ID   SMF No.5
AC   CVCL_0H70
DR   SKIP; SKIP000565
DR   Wikidata; Q54954950
RX   PubMed=24859480;
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=24859480).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
RX   PubMed=24859480; DOI=10.1016/j.exphem.2014.03.010;
RA   Hosoi, Masataka
RA   Kumano, Keiki
RA   Taoka, Kazuki
RA   Arai, Shunya
RA   Kataoka, Keisuke
RA   Ueda, Koki
RA   Kamikubo, Yasuhiko
RA   Takayama, Naoya
RA   Otsu, Makoto
RA   Eto, Koji
RA   Nakauchi, Hiromitsu
RA   Kurokawa, Mineo
RT   "Generation of induced pluripotent stem cells derived from primary and
RT   secondary myelofibrosis patient samples.";
RL   Exp. Hematol. 42:816-825(2014).
//